§ Funding Round
Series B funding round for LakeShore Biopharma raising $130M in February 2021
Series B funding round for LakeShore Biopharma raising $130M in February 2021
| Investor | Firm Type | Partner |
|---|---|---|
OrbiMedLEAD | Organization | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Haitong International | — | — |
Hillhouse Capital | — | — |
| Organization | — | |
dave chennLEAD | Angel | dave chenn |
| Organization | — |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$130M
Top Valuation
-
LakeShore Biopharma raised $130M in a Series B round.
The round was announced on 02/01/21.
The round was led by OrbiMed, dave chenn.
